---
title: 에이비엘바이오 (298380)
categories:
- KOSDAQ
- Q:제약
- 고PER
- 고PBR
---
| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 21,650 | <span style="color: red">0.5<small>%</small></span> | Q:제약 | 323.1 | 14.9 | - |

<!-- more -->

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>


| **제출일** | **보고서명** |
| :--------- | :----------- |
| 01-18 | [투자판단관련주요경영사항(임상시험계획변경승인)(이중항체 파킨슨병 치료제 ABL301의 미국 FDA 제1상 임상시험계획 (IND) 변경 승인)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240118900062){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![298380](/stock/images/298380.png)

> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 21,650 | <span style="color: red">0.5<small>%</small></span> | <span style="color: blue">-3.6<small>%</small></span> | <span style="color: blue">-0.2<small>%</small></span> | <span style="color: red">39.4<small>%</small></span> | <span style="color: red">19.9<small>%</small></span> |
| **1년** | **표준편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: red">9.3<small>%</small></span> | 44.8<small>%</small> | 0.21 | -39.3<small>%</small> | -17.0<small>%</small> | 0.2 |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![298380](/stock/images/298380_tech.png)

| **기술 지표** | **1년** | **표준편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 9.3<small>%</small> | 44.8<small>%</small> | 0.21 | -39.3<small>%</small> | -17.0<small>%</small> |
| SMA (5, 20)<small>[^fn_tech_metric_sma]</small> | -38.1<small>%</small> | 31.5<small>%</small> | -1.21 | -47.5<small>%</small> | -27.6<small>%</small> |
| SMA (20, 60)<small>[^fn_tech_metric_sma]</small> | -14.3<small>%</small> | 29.1<small>%</small> | -0.49 | -36.9<small>%</small> | -19.7<small>%</small> |
| MACD (12, 26, 9)<small>[^fn_tech_metric_macd]</small> | -23.9<small>%</small> | 35.9<small>%</small> | -0.67 | -38.8<small>%</small> | -20.7<small>%</small> |
| C_SMA (5, 20, 60)<small>[^fn_tech_metric_c_sma]</small> | -19.5<small>%</small> | 22.7<small>%</small> | -0.86 | -32.4<small>%</small> | -17.8<small>%</small> |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 323.1 | 14.9 | - | 고PER, 고PBR |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![298380](/stock/images/298380_corr.png)

|    | [HLB생명과학](/067630/) | [녹십자홀딩스](/005250/) | [넷마블](/251270/) |
| :- | :------------------------------------- | :------------------------------------- | :--------------------------------------|
|    | [HLB](/028300/) | [지씨셀](/144510/) | [에코프로머티](/450080/) |
|    | [녹십자](/006280/) | [커넥트웨이브](/119860/) | [카카오](/035720/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![298380](/stock/images/298380_2x.png)

---
{% include commons/footnotes.md %}